The quality control laboratory facilitates the acceleration of drug development, supporting Clinical Phase I and II studies. From method development/implementation, clinical formulation development, validation/qualification of analytical methods to supporting stability and compatibility studies and quality control analysis of GMP drug product batches.
PRA's Laboratories for Drug Development
We provide end-to-end (bio)analytical support to drug development from pre-clinical up to Phase IV studies.
ECG Assessments in Renal and Hepatic Impaired Patients
PRA’s dedicated early phase professionals leverage proven expertise in renal and hepatic impairment to provide clients with high quality ECG…